Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mikus (Stockholm, Sweden), J. Kolmert (Stockholm, Sweden), A. James (Stockholm, Sweden), L. Andersson (Stockholm, Sweden), J. Östling (Mölndal, Sweden), C. Gomez (Stockholm, Sweden), R. Knowles (Stevenage, United Kingdom), B. Dahlén (Stockholm, Sweden), R. Djukanovic (Southampton, United Kingdom), I. Adcock (London, United Kingdom), P. Nilsson (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden). Plasma protein profiles as markers of asthma severity and exposure to oral corticosteroids in U-BIOPRED and BIOAIR. 5278

Member's Comments

No comment yet.

Related content which might interest you: Increased serum MMP-3 in severe asthma is associated with oral steroid use; data from U-BIOPRED and BIOAIR cohorts Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005 Serum and urine eosinophil markers in children and adolescents with asthma treated with once or twice daily inhaled glucocorticoids Source: Eur Respir J 2001; 18: Suppl. 33, 449s Year: 2001 Genome-wide association study of asthma exacerbations in European children treated with inhaled corticosteroids Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Prevalence of oral corticosteroid use in the German severe asthma population Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019 Year: 2019 Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Source: Eur Respir J, 59 (2) 2100142; 10.1183/13993003.00142-2021 Year: 2022 Effect of urbanisation on the relationship between total serum IgE and asthma Source: Eur Respir J 2013; 41: 1074-1081 Year: 2013 Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002 The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children. Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE) Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics Source: International Congress 2016 – Systemic biomarkers Year: 2016 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021